INTERNATIONAL PATENT: PAM THERAGNOSTICS GMBH FILES APPLICATION FOR "MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION"

GENEVA, May 18 -- PAM THERAGNOSTICS GMBH (Neuendorfstr. 15 B16761 Hennigsdorf) filed a patent application (PCT/EP2025/081946) for "MODIFIED AND UNMODIFIED PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR USE IN SUBJECTS HAVING INCREASED AMYLOID-BETA AND/OR PHOSPHO-TAU-PROTEIN LOAD AND/OR NEUROINFLAMMATION" on Nov 05, 2025. With publication no. WO/2026/099249, the details related to the patent application was published on May 15, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERGMANN, Andreas (c/o PAM Theragnostics GmbHNeuendorfstr. 15 B16761 Hennigsdorf), ILINA, Yulia (c/o PAM Thera...